CCR2 — Drug Target

All drugs that target CCR2 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

CCR2 antagonist · CCR2 antagonist monoclonal antibody

Phase 3 pipeline (1)

• SR34006 · Sanofi · CCR2 antagonist · Immunology
  SR34006 is a selective antagonist of the chemokine receptor CCR2, which blocks the recruitment of monocytes and inflammatory cells to sites of inflammation.

Phase 2 pipeline (2)

• BTT1023 · Biotie Therapies Corp. · CCR2 antagonist monoclonal antibody · Immunology
  BTT1023 is a monoclonal antibody that blocks the CC chemokine receptor 2 (CCR2) to reduce inflammatory cell recruitment and immune activation.
• ABT-530 · AbbVie · CCR2 antagonist · Immunology
  ABT-530 is a selective inhibitor of the chemokine receptor CCR2 that reduces inflammatory monocyte recruitment to sites of inflammation.